eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Comorbidity | C0020456|hyperglycaemia |
| Sentences | 6 |
| PubMedID- 25665169 | On the contrary, icr mice fed a high-fat diet displayed symptoms of metabolic syndrome with hyperglycaemia, hyperlipidaemia and obesity. |
| PubMedID- 23942780 | Common risk factors for t2dm include physical inactivity, smoking, alcohol abuse and environmental toxins, such as bisphenol a. in addition, hypertension, obesity and hyperglycaemia, 3 major hallmarks of metabolic syndrome, have been associated with increased plasma levels of angiotensin(ang) ii, a central component of the renin-angiotensin system (ras) (7–9). |
| PubMedID- 21890532 | Aims: methylglyoxal (mg) overproduction has been reported in metabolic syndrome with hyperglycaemia (diabetes) or without hyperglycaemia (hypertension), and the underlying mechanism was investigated. |
| PubMedID- 25083916 | Agonists of the nuclear receptor ppargamma are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. |
| PubMedID- 22913986 | For example, clock/clock mutant mice become obese and develop metabolic syndrome with hepatic steatosis, hyperglycaemia, hypertriglyceridaemia, hypercholesterolaemia and hyperleptinaemia (turek et al., 2005). |
| PubMedID- 25861250 | The agonists of ppars are therapeutically used to treat dyslipidemia and hyperglycaemia associated with the metabolic syndrome. |
Page: 1